Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues: A Descriptive Study
| Registry | NCT06222424 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, supportive care |
| Enrollment | 350 (Actual) |
| Sponsor | Methodist Health System (Other) |
| Conditions | Outpatient Prescription Issues |
| Interventions | outpatient prescription issues (Other) |
| Dates | start 2023-12-15, primary completion 2026-03-01, completion 2026-03-15, first posted 2024-01-24, last updated 2026-03-23 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Outpatient Prescription Issues All trials of outpatient prescription issues
The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.
Use of an EMP CPA, which allows for broad prescriptive authority, will assist Emergency Department (ED )workflow by preventing a significant volume of new prescriptions needing to be sent by physician and mid-level providers. Will improve rates of ED re-visits. In addition, this Collaborative Practice Agreement (CPA) will not be associated with a large volume of new prescription errors.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 | Other | Other: outpatient prescription issues | Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge. |
Sex: All
Inclusion Criteria: * Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP. Exclusion Criteria: * CPA actions were misclassified as discharge prescription issue resolutions. * Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions. * Patients documented to have left the ED against medical advice.
| Facility | City | Country | Status |
|---|---|---|---|
| Clinical Research Institute at Methodist Health System | Dallas, Texas | United States |